Your browser doesn't support javascript.
loading
Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.
Ojal, John; Flasche, Stefan; Hammitt, Laura L; Akech, Donald; Kiti, Moses C; Kamau, Tatu; Adetifa, Ifedayo; Nurhonen, Markku; Scott, J Anthony G; Auranen, Kari.
Afiliação
  • Ojal J; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: jojal@kemri-wellcome
  • Flasche S; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Hammitt LL; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Akech D; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya.
  • Kiti MC; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya.
  • Kamau T; Kenya Ministry of Health, Nairobi, Kenya.
  • Adetifa I; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Nurhonen M; Department of Public Health Solutions, National Institute for Health and Welfare (THL), Finland.
  • Scott JAG; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Auranen K; Department of Public Health Solutions, National Institute for Health and Welfare (THL), Finland; Department of Mathematics and Statistics, University of Turku, Finland.
Vaccine ; 35(35 Pt B): 4561-4568, 2017 08 16.
Article em En | MEDLINE | ID: mdl-28729018
ABSTRACT

BACKGROUND:

In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a catch-up campaign for children aged <5years in Kilifi County. In a post-vaccination surveillance study based in Kilifi, there was a substantial decline in invasive pneumococcal disease (IPD). However, given the continued circulation of the vaccine serotypes it is possible that vaccine-serotype disease may re-emerge once the effects of the catch-up campaign wear off.

METHODS:

We developed a compartmental, age-structured dynamic model of pneumococcal carriage and invasive disease for three serotype groups the 10-valent vaccine serotypes and two groups of non-vaccine serotypes based on their susceptibility to mutual competition. The model was calibrated to age- and serotype-specific data on carriage and IPD in the pre-vaccination era and used to predict carriage prevalence and IPD up to ten years post-vaccination in Kilifi. The model was validated against the observed carriage prevalence after vaccine introduction.

RESULTS:

The model predicts a sustained reduction in vaccine-type pneumococcal carriage prevalence from 33% to 8% in infants and from 30% to 8% in 1-5year olds over the 10-year period following vaccine introduction. The incidence of IPD is predicted to decline across all age groups resulting in an overall reduction of 56% in the population, corresponding to 10.4 cases per 100,000 per year. The vaccine-type IPD incidence is estimated to decline by 83% while non-vaccine-type IPD incidence is predicted to increase by 52%. The model's predictions of carriage prevalence agrees well with the observed data in the first five years post-vaccination.

CONCLUSION:

We predict a sustained and substantial decline in IPD through PCV vaccination and that the current regimen is insufficient to fully eliminate vaccine-serotype circulation in the model. We show that the observed impact is likely to be sustained despite waning effects of the catch-up campaign.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Portador Sadio / Monitoramento Epidemiológico Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Vaccine Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Portador Sadio / Monitoramento Epidemiológico Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Vaccine Ano de publicação: 2017 Tipo de documento: Article